Connect with a local CRO at BIO Asia-Taiwan.  We are located in the Australian Pavilion, L332, in #8.

Members of our team will be there to speak with you about potential collaboration, and on running FIH/FIP in Australia.

• John Lin, Country Manager
• Kelly Yang, Early Phase Project Director
• Local PMs

Along with Early Phase Trials in Australia, we provide full services for Phase I-IV in APAC, US and EU regions.

BIO Asia–Taiwan 2023 Onsite + Online will be held July 26-30, in Taipei, Taiwan. The event aims to build on the success of recent years’ gatherings to bring together biotechnology and pharmaceutical executives and investors from North America, Europe and Asia, and explore business opportunities and to engage with Taiwan’s emerging biotech sector. The five-day gathering will feature a three-day conference with internationally-renowned speakers, company presentations from Asia and around the world, BIO One-on-One Partnering™ meetings, symposia and workshops, and an international exhibition. Each element of the gathering will also be accessible online in either live or on-demand formats; ideal for repeat viewings or for delegates unable to attend in person. Online participation in 2022 was impressive, with 13,000 online conference and 215,000 online exhibition views.

The conference will focus on three major topic areas:
Innovation – covering precision health, AI and digital health, and others.
Market & Supply – including biosimilars, vaccines, contract development & manufacturing, APIs and generics, among others.
Investment – covering early-stage financing, cross border investment, capital markets, and more.